Jonathan Couchman, 10% Owner at ENZON PHARMACEUTICALS, INC. (ENZN), bought 31,000 shares at $0.25 ($8K) on 2019-02-11, disclosed to the SEC on 2019-02-14.
Open-market purchase of $8k ENZN by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.25 | 500 | $125 | 1.6% |
| 2 | $0.25 | 5,000 | $1K | 16.1% |
| 3 | $0.25 | 10,000 | $3K | 32.3% |
| 4 | $0.25 | 15,500 | $4K | 50.0% |
| Total | $0.25 avg | 31,000 | $8K | 100% |
| Filing → |
| ENZN | BUY | 2019-01-09 | $379K | — | Filing → |